| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2024 | Jul 1, 2024 | GYRE THERAPEUTICS, INC. | Director | Sell | 13.8 | -3,452 | -60.27% | ✓ | $41.4K |
| May 1, 2024 | May 2, 2024 | GYRE THERAPEUTICS, INC. | Director | Sell | 7.5 | -20,000 | -89.78% | ✓ | $282.6K |
| Apr 1, 2024 | Apr 3, 2024 | GYRE THERAPEUTICS, INC. | Director | Sell | 7.5 | -20,000 | -89.78% | ✓ | $323K |
| Mar 15, 2024 | Mar 19, 2024 | GYRE THERAPEUTICS, INC. | Director | Sell | 7.5 | -20,000 | -89.78% | ✓ | $345.2K |
| Aug 9, 2022 | Aug 10, 2022 | GYRE THERAPEUTICS, INC. | CEO | Buy | 90.0 | +3,250 | 10.51% | ✗ | $1.5K |
| Feb 9, 2022 | Feb 16, 2022 | GYRE THERAPEUTICS, INC. | CEO | Buy | 90.0 | +3,250 | 11.75% | ✗ | $1.5K |
| Aug 9, 2021 | Aug 11, 2021 | GYRE THERAPEUTICS, INC. | CEO | Buy | 82.5 | +867 | 3.24% | ✗ | $3.1K |
| Feb 9, 2021 | Feb 22, 2021 | GYRE THERAPEUTICS, INC. | CEO | Buy | 82.5 | +582 | 2.74% | ✗ | $2.8K |
| Aug 10, 2020 | Aug 12, 2020 | GYRE THERAPEUTICS, INC. | CEO | Buy | 82.5 | +582 | 2.82% | ✗ | $2.8K |
| Mar 13, 2020 | Mar 13, 2020 | GYRE THERAPEUTICS, INC. | CEO | Buy | 91.3 | +4,000 | 24.05% | ✗ | $15.6K |
| Dec 17, 2015 | Dec 18, 2015 | GYRE THERAPEUTICS, INC. | CEO | Buy | 82.5 | +4,000 | 2.96% | ✗ | $8K |